Roxanna Perez, PHARM.D
Ambulatory Care Pharmacist in Los Angeles, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,709 in Ambulatory Care Pharmacist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Roxanna Perez, PHARM.D filed 596 Medicare Part D claims in 2024 as an Ambulatory Care Pharmacist in Los Angeles, California, prescribing 51% generic.
- 596
- Part D claims, 2024
- 51%
- generic prescribing
- ≥65th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Roxanna Perez, PHARM.D
Bare NPI registry listing — limited federal enrichment beyond basic enumeration. Verify all credentials with official sources.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1679130330), first enumerated 05/28/2019.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 596 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- State context
State board disciplinary context
California statewide board action statistics are published annually — these figures describe aggregate state activity, not Roxanna Perez, PHARM.D's individual license status. Verify directly with the state medical board.
Source: MBC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1679130330 · Ambulatory Care Pharmacist
NPI-10 · ENUM-RECENT · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1679130330
- ENUM-RECENT 2019
- TAX-NARROW 3,709
- RX-LIGHT 596
- BOOK-THIN 451 in California
- PHOTO-ENUM Brittany Maniga, PHA… · 2019
Roxanna Perez, PHARM.D's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
596 ≥ 65th percentile 65% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
What does the federal data show about Roxanna Perez, PHARM.D?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in California
How Ambulatory Care Pharmacist compares to other specialties among California providers
Ambulatory Care Pharmacist ranks #140 among California's specialties (0% of in-state providers)
Each bar is a specialty's share of the California provider total, by primary NUCC taxonomy. The highlighted bar is Ambulatory Care Pharmacist; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Ambulatory Care Pharmacist. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1679130330 |
|---|---|
| Specialty | Ambulatory Care Pharmacist |
| Credentials | PHARM.D |
| Gender | Female |
| NPI Issued | 05/28/2019 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Roxanna Perez, PHARM.D's current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1679130330 is the unique 10-digit identifier CMS uses to link Perez across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Roxanna Perez, PHARM.D. To verify Roxanna Perez, PHARM.D's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
42% brand-name claims vs 51% generic, on 596 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 1,698.367
- Total Day Supply
- 50,793
- Brand vs Generic
- 42% brand / 51% generic
- Brand Drug Cost
- $97K
- Generic Drug Cost
- $4K
Patient Demographics
- Average Patient Age
- 72.0 years
- Avg HCC Risk Score
- 1.18
- Gender Split
- 52% female / 48% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Roxanna Perez, PHARM.D prescribes most
Top Medicare Part D drugs by claim count, 2024
- Metformin Hcl Er
Metformin Hcl Er
71 claims
- Ozempic
Ozempic
70 claims
- Atorvastatin Calcium
Atorvastatin Calcium
39 claims
- Humulin N
Humulin N
39 claims
- Glipizide
Glipizide
37 claims
- Insulin Glargine-Y…
Insulin Glargine-Yfgn
34 claims
- Jardiance
Jardiance
31 claims
- Metformin Hcl 27
Metformin Hcl
27 claims
| Drug | Claims |
|---|---|
| Metformin Hcl Er Metformin Hcl | 71 |
| Ozempic Semaglutide | 70 |
| Atorvastatin Calcium | 39 |
| Humulin N Insulin Nph Human Isophane | 39 |
| Glipizide | 37 |
| Insulin Glargine-Yfgn | 34 |
| Jardiance Empagliflozin | 31 |
| Metformin Hcl | 27 |
| Humulin 70-30 Insulin Nph Hum/Reg Insulin Hm | 23 |
| Amlodipine Besylate | 20 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ambulatory Care Pharmacist Overview
How Roxanna Perez, PHARM.D fits within the Ambulatory Care Pharmacist landscape nationally.
Roxanna Perez, PHARM.D's 596 claims are above the specialty average of 526.
Nationwide Ambulatory Care Pharmacist peers with similar MIPS or enrollment year
Two federal-record peer sets for Perez, both outside California so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2019)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Ambulatory Care Pharmacist Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Perez.
One of 451 Ambulatory Care Pharmacist providers enrolled in California, 5 are shown here.
Compare Ambulatory Care Pharmacist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Roxanna Perez, PHARM.D's specialty? ▼
How much does Roxanna Perez, PHARM.D prescribe under Medicare Part D? ▼
Where is Roxanna Perez, PHARM.D located? ▼
What is Roxanna Perez, PHARM.D's NPI number? ▼
Does Roxanna Perez, PHARM.D prescribe more brand-name or generic drugs? ▼
How many Ambulatory Care Pharmacist providers are there in the US? ▼
What drugs does Roxanna Perez, PHARM.D prescribe most often? ▼
Does Roxanna Perez, PHARM.D accept Medicare? ▼
How can I verify Roxanna Perez, PHARM.D's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.